1.1900
+0.0200
+(1.71%)
At close: 3:29:02 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,132.7490
-1,376.3510
-215.3950
-5,274.9490
Investing Cash Flow
343,049.9300
342,916.9300
--
-109.7270
Financing Cash Flow
-334,881.6020
-341,660.9300
--
12,500
End Cash Position
6,642.1980
8.8350
129.1860
7,119.1620
Capital Expenditure
--
--
-479.0420
-109.7270
Issuance of Debt
-1,326.5000
1,323.5000
--
12,500
Repurchase of Capital Stock
--
-342,984.4300
--
--
Free Cash Flow
-3,999.7490
-1,376.3510
-215.3950
-5,384.6760
12/31/2021 - 2/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVBIY Innovent Biologics Inc.
19.15
-12.95%
4RY.DU Akeso Inc
8.35
-4.57%
IOBT IO Biotech, Inc.
0.8633
-8.65%
OSTX OS Therapies Incorporated
1.4400
-12.73%
9926.HK Akeso, Inc.
71.400
-2.12%
BRTX BioRestorative Therapies, Inc.
1.5100
-0.66%
CABA Cabaletta Bio, Inc.
1.6700
-7.48%
ADIL Adial Pharmaceuticals, Inc.
0.7310
-6.88%
MESO Mesoblast Limited
15.41
-10.15%
SANA Sana Biotechnology, Inc.
2.4300
-6.90%